SCHEMBL5909720

SCHEMBL5909720

FC(F)(F)c1cc([B-](c2ccccc2)(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc(C(F)(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
TSHR P16473 1/20 0.48
KIF11 P52732 1/20 0.46
P2RX1 P51575 1/20 0.41
IDO1 P14902 1/20 0.41
TDO2 P48775 1/20 0.41
TACR1 P25103 9/20 0.39
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
METAP2 P50579 1/20 0.37
CACNA1F O60840 1/20 0.37
CACNA1D Q01668 1/20 0.37
CACNA1S Q13698 1/20 0.37
CACNA1C Q13936 1/20 0.37
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
RXRG P48443 1/20 0.36
BACE1 P56817 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15065839 1.00 ALDH1A1 (0.48) ALDH1A1TSHRKIF11P2RX1IDO1
Benzene SCHEMBL30336225 0.91 TSHR (0.43) ALDH1A1TSHRKIF11P2RX1IDO1
SCHEMBL22105646 0.89 TAS2R14 (0.40) ALDH1A1TSHRKIF11P2RX1IDO1
SCHEMBL41567 0.86 CES2 (0.44) ALDH1A1TSHRKIF11IDO1RXRA
Aniline SCHEMBL1010731 0.86 ALDH1A1 (0.43) ALDH1A1TSHRKIF11P2RX1IDO1
SCHEMBL25633935 0.85 TAS2R14 (0.40) ALDH1A1TSHRKIF11P2RX1IDO1
SCHEMBL215855 0.84 ALDH1A1 (0.41) ALDH1A1TSHRKIF11P2RX1IDO1
SCHEMBL3244276 0.84 TSHR (0.41) ALDH1A1TSHRKIF11P2RX1IDO1
Toluene SCHEMBL6239727 0.84 TSHR (0.41) ALDH1A1TSHRKIF11P2RX1IDO1
Toluene SCHEMBL6538388 0.84 TSHR (0.41) ALDH1A1TSHRKIF11P2RX1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230384671-A1 LAMINATE OF NEGATIVE TONE LITHOGRAPHIC PRINTING PLATE PRECURSOR AND METHOD OF PREPARING NEGATIVE TONE LITHOGRAPHIC PRINTING PLATE FUJIFILM CORPORATION (JP) 2023-11-30 US disclosed
WO-2023191080-A1 POLYETHYLENE POWDER AND METHOD FOR PRODUCING SAME, AND OLEFIN POLYMERIZATION CATALYST AND METHOD FOR PRODUCING SAME 旭化成株式会社 2023-10-05 WO disclosed
WO-2023054514-A1 ULTRAHIGH-MOLECULAR-WEIGHT POLYETHYLENE POWDER AND SHAPED OBJECT OBTAINED BY SHAPING SAME 旭化成株式会社 2023-04-06 WO disclosed
US-11567404-B2 Lithographic printing plate precursor, method for making lithographic printing plate, organic polymer particle, and photosensitive resin composition FUJIFILM CORPORATION (JP) 2023-01-31 US disclosed
US-11331900-B2 Lithographic printing plate precursor and method for producing lithographic printing plate FUJIFILM CORPORATION (JP) 2022-05-17 US disclosed
US-11333977-B2 Curable composition, lithographic printing plate precursor, method for producing lithographic printing plate, and compound FUJIFILM CORPORATION (JP) 2022-05-17 US disclosed
US-11117364-B2 Color developing composition, lithographic printing plate precursor, method for producing lithographic printing plate, and compound FUJIFILM CORPORATION (JP) 2021-09-14 US disclosed
US-20210181631-A1 PLANOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING PLANOGRAPHIC PRINTING PLATE, PLANOGRAPHIC PRINTING METHOD, AND CURABLE COMPOSITION FUJIFILM CORPORATION (JP) 2021-06-17 US disclosed
US-10921712-B2 Color developing composition, lithographic printing plate precursor, method for producing lithographic printing plate, and color developing compound FUJIFILM CORPORATION (JP) 2021-02-16 US disclosed
US-20200164629-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR AND METHOD FOR PRODUCING LITHOGRAPHIC PRINTING PLATE FUJIFILM CORPORATION (JP) 2020-05-28 US disclosed
US-20200094542-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD FOR PRODUCING LITHOGRAPHIC PRINTING PLATE, POLYMER PARTICLE, AND COMPOSITION FUJIFILM CORPORATION (JP) 2020-03-26 US disclosed
US-20190184696-A1 COLOR DEVELOPING COMPOSITION, LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD FOR PRODUCING LITHOGRAPHIC PRINTING PLATE, AND COMPOUND FUJIFILM CORPORATION (JP) 2019-06-20 US disclosed
US-20190187557-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR AND PLATE-MAKING METHOD USING SAME FUJIFILM CORPORATION (JP) 2019-06-20 US disclosed
US-20190160848-A1 CURABLE COMPOSITION, LITHOGRAPHIC PRINTING PLATE PRECURSOR, AND METHOD FOR PRODUCING LITHOGRAPHIC PRINTING PLATE FUJIFILM CORPORATION (JP) 2019-05-30 US disclosed
US-10241400-B2 Color developing composition, lithographic printing plate precursor, plate making method for lithographic printing plate, and color developer FUJIFILM CORPORATION (JP) 2019-03-26 US disclosed
US-9469701-B2 Polyethylene powder ASAHI KASEI CHEMICALS CORPORATION (JP) 2016-10-18 US disclosed
US-20160137760-A1 Polyethylene Powder ASAHI KASEI CHEMICALS CORPORATION (JP) 2016-05-19 US disclosed
US-20060287449-A1 Ultrahigh-molecular ethylene polymer ASAHI KASEI CHEMICALS CORPORATION (JP) 2006-12-21 US disclosed
US-6956002-B2 Process for polymerization of olefins ASAHI KASEI CHEMICALS CORPORATION (JP) 2005-10-18 US disclosed
US-20040254314-A1 Process for polymerization of olefins ASAHI KASEI CHEMICALS CORPORATION (JP) 2004-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11333977-B2 Curable composition, lithographic printing plate precursor, method for producing lithographic printing plate, and compound S100P, LBR, SALL4 ALDH1A1 3490/4885TSHR 4604/4885KIF11 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.